Acid–base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone

Abstract

Metabolic regulation of cerebrovascular tone directs blood flow to areas of increased neuronal activity and during disease states partially compensates for insufficient perfusion by enhancing blood flow in collateral blood vessels. Acid–base disturbances frequently occur as result of enhanced metabolism or insufficient blood supply, but despite definitive evidence that acid–base disturbances alter arterial tone, effects of individual acid–base equivalents and the underlying signaling mechanisms are still being debated. H⁺ is an important intra- and extracellular messenger that modifies cerebrovascular tone. In addition, low extracellular [HCO₃^–] promotes cerebrovascular contraction through an endothelium-dependent mechanism. CO₂ alters arterial tone development via changes in intra- and extracellular pH but it is still controversial whether CO₂ also has direct vasomotor effects. Vasocontractile responses to low extracellular [HCO₃^–] and acute CO₂-induced decreases in intracellular pH can counteract H⁺-mediated vasorelaxation during metabolic and respiratory acidosis, respectively, and may thereby reduce the risk of capillary damage and cerebral edema that could be consequences of unopposed vasodilation. In this review, the signaling mechanisms for acid–base equivalents in cerebral arteries and the mechanisms of intracellular pH control in the arterial wall are discussed in the context of metabolic regulation of cerebrovascular tone and local perfusion.

Keywords

Cerebral blood flow metabolism neurovascular coupling penumbra pH

Neurovascular coupling matches local blood flow to the metabolic demand of the tissue and the requirement for waste product elimination. This regulation of cerebrovascular tone in response to changes in metabolic activity supports normal neuronal function and reduces the consequences of cerebrovascular pathologies. Responses to acid–base deviations are also important for physiological and pathophysiological adaptations during systemic disturbances, for instance, in patients with pulmonary, renal, or metabolic disease.

Outside the nervous system, crosstalk between perivascular tissue and arteries has been demonstrated for coronary,^1,2 skeletal muscle,³ subcutaneous,⁴ and mesenteric^5,6 arteries and probably is of general importance in the resistance vasculature—albeit with some variation in the magnitude of influence between different vascular beds. Signaling between perivascular tissue and arteries can be bi-directional involving paracrine factors released, among others, from neurons, glial cells, cardiomyocytes, skeletal muscle, and adipocytes in the perivascular tissue^1,7–10 but also from endothelial cells in the vascular wall.¹¹ Moreover, metabolites in the interstitial space are potential bi-directional signals as their concentrations are sensitive to the local metabolic rate and also respond to changes in perfusion that alter the delivery of nutrients and lead to local washout or accumulation of waste products. Deregulated local communication has been implicated in neurological (e.g. epilepsy¹² and Alzheimer’s disease¹³) and metabolic (e.g. diabetes² and obesity^4,14) disorders. Although the cause-effect relationship is still largely unclear, the homeostatic imbalance resulting from disturbed signaling between perivascular tissue and arteries likely contributes to disease development. Unravelling disease-related alterations in metabolic blood flow regulation remains an important current challenge.¹⁵

Mechanisms of cerebrovascular control include responses to acid–base disturbances, hypoxia, and extracellularly accumulated adenosine and K⁺, and relies in part on vasoactive neurotransmitters and local paracrine factors (e.g. gasotransmitters and prostanoids).¹⁶ Cellular responses to acid–base disturbances have become increasingly understood through the identification of putative intra- and extracellular sensors of acid–base equivalents. The function of many ion channels^17,18 and enzymes^19–22 is modulated by local extracellular (o) and/or intracellular (i) pH. In addition, G-protein-coupled receptors sensitive to pH_o²³ and membrane-bound or intracellular enzymes sensitive to [HCO₃^–]_o or [HCO₃^–]_i^24–26 have been identified. Molecular interventions to knockout, downregulate or overexpress the novel acid–base sensors in cultured cells, isolated tissues, and in vivo have proven valuable in the initial mapping of downstream signaling consequences:^24,27–29 by selectively eliminating effects of individual putative acid–base sensors, it is possible to dissect functional roles and involved signaling cascades despite parallel activation of interdigitating messenger systems.

The molecular physiology of the signaling pathways modified by acid–base equivalents has been intensively studied but difficult to establish conclusively because of the spontaneous chemical reactions: CO₂ + H₂O ⇄ H₂CO₃ ⇄ HCO₃^–+ H⁺ that interlink the CO₂/HCO₃^– buffer components. Under standard experimental conditions—where the CO₂/HCO₃^– buffer is in equilibrium—it is not possible to vary one of the parameters [HCO₃^–], pCO₂, or pH while keeping the other two constant. However, because of the relatively slow equilibration of the spontaneous reaction CO₂ + H₂O ⇄ H₂CO₃, the interdependency of [HCO₃^–], pCO₂, and pH can be circumvented using out-of-equilibrium solutions that are based on continuous rapid mixing and delivery of solutions with different HCO₃^–/CO₂/H⁺ composition.³⁰ The out-of-equilibrium technique is an essential tool for mechanistic studies of acid–base sensing as it allows investigators to subject cerebrovascular preparations to experimental solutions with virtually any desired combination of [HCO₃^–], pCO₂, and pH.^24,31

Although the highlighted technical advances and new molecular information have furthered our understanding of acid–base transport and sensing in the cerebrovascular wall, additional functional and molecular information is required in order to accelerate the rational development of therapeutics for diverse cerebrovascular disease manifestations such as stroke and neurodegenerative disorders. In particular, in vivo investigations are required to understand how intrinsic contractile responses of the vascular wall are influenced by nerve activity, circulating hormones, and paracrine signals from perivascular tissue and immune cells. Much of our current knowledge derives from in vitro studies of isolated arteries. These studies present a risk of surgical damage during blood vessel isolation and are too simplistic to take into account the numerous interactions occurring in the intact organism. Still, in vitro studies have a number of technical advantages: (a) common cardiovascular side-effects of anesthetics required under in vivo conditions³² are avoided in studies of isolated tissues, (b) acid–base parameters are much more easily manipulated than under in vivo conditions where local perfusion and metabolism as well as systemic renal and respiratory functions need to be monitored and controlled, (c) conclusive evidence regarding molecular mechanisms can more easily be reached, for instance, based on out-of-equilibrium technology,^24,31 and (d) cell type-specific recordings of intracellular ion dynamics (e.g. pH_i and [Ca²⁺]_i) and membrane potentials can be performed by advanced imaging techniques^19,33 more easily than in vivo where transgenic models expressing genetically encoded fluorophores may be required to ensure proper restriction of dyes to the desired cell type.³⁴ With the current technical limitations, in vivo and in vitro studies must generally be combined to accomplish the dual goal of identifying molecular mechanisms of acid–base-mediated vasomotor control and extrapolating their importance to integrated physiological and pathophysiological conditions.

The current review highlights and discusses the mechanisms and importance of acid–base regulation and sensing in the cerebrovascular wall in the context of metabolic regulation of cerebrovascular tone and development of cardiovascular disease.

Acid–base regulation in the vascular wall

Due to the inside-negative membrane potential and net metabolic production of acid equivalents, cells—including those of the vascular wall—are usually prone to developing intracellular acidification. At a membrane potential of –50 mV and pH_o 7.4 ([H⁺]≈40 nM), H⁺ is at equilibrium across the plasma membrane when pH_i is around 6.6 ([H⁺]≈260 nM). The typical resting pH_i in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), however, is around 7.1–7.3 ([H⁺]≈50–80 nM),^19,35–38 and hence net acid extrusion is needed to maintain normal intracellular acid–base homeostasis.

When arteries are exposed to extracellular acid–base disturbances, the intracellular environment of the cells of the vascular wall is affected to varying degrees: typically, the change in VSMC pH_i in rat and mouse resistance arteries is up to 70% of the change in pH_o when exposed to respiratory acidosis caused by elevated pCO₂ and around 50% when exposed to metabolic acidosis accompanied by reduced [HCO₃^–]_o.^24,39,40 The plasma membrane is relatively impermeable to passive movement of H⁺, yet extracellular acidification inhibits the major secondary active acid extruding transporters (see the section Net acid extrusion below).⁴⁰ As a consequence, pH_i falls during extracellular acidosis until a new steady-state is reached where net acid extrusion—which increases as function of decreasing pH_i—again matches the metabolic acid production, H⁺ leaks through the plasma membrane, and any net base extrusion. The pH_i value corresponding to this new steady-state depends on the pH_o- and pH_i-sensitivities of the involved membrane acid–base transporters and metabolic pathways, which explains the variation between different cell types. VSMCs of mouse basilar arteries are better protected against intracellular acidification than intracellular alkalinization during equivalent changes in pH_o.²⁴ The greater tendency for changes in pCO₂ than [HCO₃^–]_o to affect VSMC pH_i⁴⁰ and the vasocontractile effect of lowering [HCO₃^–]_o per se²⁴ may explain why hyper- and hypocapnia with parallel changes in [HCO₃^–]_o in some—albeit not all—studies are found to change vasomotor tone beyond the expected based on the change in pH_o.⁴¹ Indeed, current evidence supports that vasomotor adaptations in response to extracellular acidification are partly explained by the associated decrease in pH_i,^24,42 which—as discussed later—can lead to vasoconstriction in the acute phase^31,43 but attenuates the Ca²⁺-sensitivity of the VSMC contractile machinery and relaxes arteries at steady-state.^19,35,38,44 The effects of pH_i-changes on vasomotor function highlight the need for cells to regulate intracellular acid–base conditions.

Net acid extrusion

Membrane proteins—particularly Na⁺,HCO₃^–-cotransporters of the Slc4-family and Na⁺/H⁺-exchangers of the Slc9-family—contribute to net elimination of intracellular acid equivalents from cells. Net acid extrusion from VSMCs and ECs in resistance arteries takes place predominantly via NBCn1 (Slc4a7)-mediated Na⁺,HCO₃^–-cotransport, and NHE1 (Slc9a1)-mediated Na⁺/H⁺-exchange.^{19,33,35,38,44} These secondary active transporters use the electrochemical gradient for Na⁺ to export intracellular acid equivalents^45–47 (Figure 1). Whereas NHE1 has high capacity and quantitatively dominates net acid extrusion from VSMCs at low pH_i, NBCn1 predominates in the near-neutral pH_i range and is particularly important for maintaining steady-state pH_i.^19,35,38 The strong increase of Na⁺/H⁺-exchange activity as function of decreasing pH_i has been explained by an intracellular allosteric H⁺-modifier site on the Na⁺/H⁺-exchangers.^48,49 In comparison, activation of NBCn1 with decreasing pH_i is more linear.^33,40,50 In the cerebrovascular circulation, the importance of NBCn1-mediated Na⁺,HCO₃^–-cotransport for net acid extrusion and steady-state pH_i control has been demonstrated in middle cerebral arteries.^35,44 The requirement for net acid extrusion from VSMCs increases during vasoconstriction because of the contraction-associated increase in intracellular acid loading.^35,51,52 The source of the increased intracellular acid load during VSMC contractions is not fully understood, but metabolic acid production and H⁺ imported via the plasma membrane Ca²⁺-ATPase^51,53 (PMCA, Figure 2) likely contribute. The increased need for net acid extrusion in VSMCs during contractions is met by augmented Na⁺,HCO₃^–-cotransport.^52,54 The rise in VSMC [Ca²⁺]_i stimulates NBCn1 through activation of the serine-threonine phosphatase calcineurin that interacts with the N-terminal cytosolic domain of NBCn1 via the PTVVIH motif of splice cassette II.^54,55

Figure 1.

Schematic showing the major pathways for net cellular acid and base extrusion in the vascular wall. Net acid extrusion takes place via NBCn1-mediated Na⁺,HCO₃^–-cotransport and NHE1-mediated Na⁺/H⁺-exchange. Net base extrusion takes place primarily via Cl^–/HCO₃^–-exchange.

Figure 2.

Schematic showing known and putative sensors for H⁺ and HCO₃^– in the vascular wall, relationships to acid–base transporters, and relevant downstream signaling pathways for regulation of arterial tone. The Ca²⁺ and H⁺ buffers partially overlap,¹³⁸ which allows acute changes in pH_i to change intracellular [Ca²⁺] and hence arterial tone. H⁺ has variable effects on different K⁺ conductances, with BK-channels inhibited and K_ATP-channels activated during intracellular acidification. Regulation of gap junction communication by pH_i is complex as some connexins are inhibited by both intracellular acidification and alkalinization.^59,139–142 BK: large-conductance Ca²⁺-activated K⁺-channel; CA: carbonic anhydrase; K_ATP: ATP-sensitive K⁺-channel; NOS: NO-synthase; PMCA: plasma membrane Ca²⁺-ATPase; VGCC: voltage-gated Ca²⁺-channels; V_m: membrane potential. The figure is adapted from Boedtkjer et al.⁴⁷; ©The International Union of Physiological Sciences and The American Physiological Society.

Cellular net acid extrusion is closely coupled to Na⁺-uptake, and it has been proposed that cellular Na⁺-overload with subsequent Ca²⁺-overload (e.g. via altered Na⁺/Ca²⁺-exchange activity) contributes to cell damage, for instance, during development of hypoxia-reoxygenation-induced endothelial dysfunction.⁵⁶ During ischemia, low pH_o and increased levels of reactive oxygen species inhibit net acid extrusion activity,^33,40 but the concomitantly low ATP levels reduce Na⁺/K⁺-ATPase activity and the ability to maintain normal cellular ion gradients. As a result, Na⁺ influx during ischemia likely exceeds the efflux capacity of the Na⁺/K⁺-ATPase. In accordance, inhibition of Na⁺/H⁺-exchange—in order to reduce the cellular Na⁺ load—has been found to minimize EC damage during hypoxia-reoxygenation.^56,57 It is likely that reactive oxygen species³³ and low pH_o⁴⁰ serve as endogenous signals that inhibit Na⁺-dependent net acid extrusion during ischemia. It is interesting that during extracellular acidosis, cells of the vascular wall appear to prefer control of [Na⁺]_i over control of pH_i,⁴⁰ which may be explained by the serious and irreversible damage (e.g. cell death) caused by cellular Na⁺- and Ca²⁺-overload compared to the largely reversible effects of low pH_i even after long duration.¹⁹

In addition to their contribution to global pH_i regulation, it is increasingly clear—as reviewed elsewhere⁵⁸—that acid–base transporters can establish pH micro-domains within and surrounding cells in areas with restricted diffusion. The transport mechanisms that control pH in local domains of VSMCs and ECs need further investigation but recent evidence supports that NBCn1—in a functional interaction with mobile buffer systems and carbonic anhydrases—can establish pH_i gradients along the length of filopodia and thereby promote VSMC migration.⁵⁰

Net base extrusion

The mechanisms governing net elimination of intracellular base in the vascular wall are not fully understood. There is little doubt that the most important mechanism of cellular net base extrusion is Cl^–/HCO₃^–-exchange^59,60 (Figure 1) but the molecular characterization is still incomplete. Expression of AE2 (Slc4a2) and AE3 (Slc4a3) has been reported in arteries but further studies are needed to support their functional importance and the consequences of their dysfunction.⁶¹ In addition to eliminating intracellular HCO₃^– during conditions of intracellular alkalinization, Cl^–/HCO₃^–-exchange in VSMCs—and maybe ECs—is also important for maintaining [Cl^–]_i above electrochemical equilibrium⁶² and thus for allowing Cl^– channel opening to cause membrane depolarization.⁴⁷

Carbonic anhydrases

Carbonic anhydrases catalyze equilibration of the CO₂/HCO₃^– buffer system via the reaction CO₂ + OH^– ⇄ HCO₃^–. Transcripts for carbonic anhydrase isoforms with demonstrated cytosolic (CAII, CAIII, and CAVII), mitochondrial (CAVβ), and extracellular (CAIV, CAIX, CAXII, and CAXIV) expression as well as CAVI typically secreted from cells are detectable in rat middle cerebral arteries.³¹ Although their function in the vascular wall is still not comprehensively understood, carbonic anhydrases can minimize pH gradients originating from local production or transmembrane flux of acid or base^50,63 and amplify pH transients in response to acute CO₂/HCO₃^– disturbances.³¹

By equilibrating the pH/CO₂/HCO₃^– conditions, carbonic anhydrases may modify sensing of distinct buffer components and contribute to vascular tone regulation. Under in vivo conditions, carbonic anhydrase inhibitors affect systemic acid–base handling—decreasing urinary net acid excretion⁶⁴ and interfering with ventilatory control⁶⁵—and the resulting acidosis dilates cerebral arteries. On the basis of its vasodilatory effect in vivo, the carbonic anhydrase inhibitor acetazolamide has been used for estimating the cerebral perfusion reserve in patients with cerebrovascular disease.⁶⁶ Direct cerebrovascular effects of carbonic anhydrase inhibitors are controversial.^31,67–71 In rat middle cerebral arteries, carbonic anhydrase inhibition minimizes pH_i transients and cerebrovascular tone development during fluctuations in the CO₂/HCO₃^– buffer system but has no effect on pH_i or artery tone at steady-state.³¹ When applied at concentrations magnitudes above what is needed for carbonic anhydrase inhibition, acetazolamide and dorzolamide relax porcine retinal arteries through pH-independent mechanisms.^71,72 In contrast to these findings, inhibition of carbonic anhydrase activity in guinea pig mesenteric arteries elevates pH_i and decreases vascular tone also under steady-state conditions.⁷³ Thus, further evaluation is still required to definitively settle the cerebrovascular functions of carbonic anhydrases and the direct vasomotor effects of pharmacological inhibitors.

Carbonic anhydrase inhibition has relatively modest consequences for global pH_i regulation in contractile, spindle-shaped VSMCs in the vascular wall.³¹ In contrast, carbonic anhydrases play important roles for local pH_i regulation in filopodia of migrating VSMCs.⁵⁰ As discussed in the section Acid–base equivalents as second messengers in vasomotor control and structural adaptations, current evidence supports that carbonic anhydrases play a key role by facilitating mobility of acid–base equivalents in the diffusion-restricted intracellular compartment of filopodia.⁵⁰

Sensing of acid–base disturbances

Protonation is an important reversible post-translational modification that affects the function and structure of most proteins. Changes in the concentration of acids and bases, for instance HCO₃^–, can also alter protein function independently of pH.²⁶ The proteins showing largest changes in activity in response to fluctuating acid–base conditions are likely candidates for acid–base sensors as they can translate even modest perturbations in for example pH or [HCO₃^–] into functionally relevant changes in cell and tissue function and initiate adaptive responses that reestablish homeostasis.

Acid–base disturbances adjust the function of VSMCs and ECs with consequences for vasoconstriction, vasorelaxation, and local tissue perfusion. The mechanisms by which acid–base disturbances affect cerebrovascular tone are still controversial, and the current evidence for cellular acid–base sensing and signaling mechanisms (Figure 2) will be discussed below. As discussed in the section Acid–base regulation in the vascular wall above, pH_i fluctuations are typically of smaller magnitude than the underlying pH_o variations during acid–base disturbances. However, the relative contribution of extracellular versus intracellular acid–base equivalents to sensing of metabolic disturbances and initiation of homeostatic responses is not yet completely clear.

Extracellular H⁺

The most obvious acid–base parameter to consider for regulation of vascular tone is extracellular H⁺, the concentration of which is increased during acidosis and decreased during alkalosis independently of the mechanistic cause. Direct vasorelaxant actions of H⁺—rather than secondary effects of CO₂ and/or HCO₃^–—are supported by the observations that vasorelaxation in response to acidosis is evident also when cerebral arteries are investigated in CO₂/HCO₃^–-free solutions⁷⁴ or under out-of-equilibrium conditions where pH_o is modified while pCO₂ and [HCO₃^–]_o are kept constant at normal physiological levels (5% and 22 mM, respectively).²⁴ The predominant role of extracellular H⁺ is further supported by the finding that reduction of rat cerebral artery tension is generally more pronounced in response to extracellular than intracellular acidification.³⁹ Still, as discussed in more detail below (see the section Intracellular H⁺), several lines of evidence support that extracellular acidification can in part relax arteries via decreases in VSMC pH_i.^24,75–77

Inhibition of voltage-gated Ca²⁺ channels with consequently decreased Ca²⁺ uptake into VSMCs and attenuated vasoconstriction seems to be the main functional effect of a pH_o decline (Figure 2). Evidence for pH_o-mediated gating of L-type Ca²⁺-channels comes from patch clamp experiments on isolated myocytes;^18,78 and the relevance for contraction of cerebral arteries is supported by reduced vasocontraction in response to depolarization with elevated extracellular [K⁺] at low pH_o also when pCO₂ and [HCO₃^–]_o are kept constant under out-of-equilibrium conditions.²⁴ Inhibition of agonist-induced vasocontraction by low pH_o is associated with the expected attenuation of the intracellular Ca²⁺ response.²⁴ Because L-type Ca²⁺-channels in many vascular preparations are absolutely necessary for sustained arterial contractions,^79,80 it is meaningless to compare vasorelaxant responses to extracellular acidification under control conditions and after inhibition of L-type Ca²⁺-channels. As a consequence, it has been difficult to establish conclusive evidence for the role of Ca²⁺-channel inhibition by extracellular H⁺ during myogenic and agonist-induced contractions. Glutamate residues in the pore region of the L-type Ca²⁺ channels have been suggested to contribute to the H⁺-mediated inhibition based on mutagenesis studies in oocyte expression systems.⁸¹ Future studies of H⁺-insensitive channel mutants in transgenic mouse models could provide more decisive evidence for the contribution of L-type Ca²⁺-channels to vasorelaxation induced by extracellular acidification.

Interestingly, H⁺ has also been suggested as a neurotransmitter contributing to neurovascular control: H⁺ is typically up-concentrated in synaptic vesicles and may therefore act as a co-transmitter released, for instance, from perivascular nerve endings.⁸²

Intracellular H⁺

Intracellular acidification in the vascular wall can occur by several mechanisms. Extracellular acid–base disturbances lead to parallel shifts in intracellular acid–base conditions, and intracellular acidification and alkalinization can therefore be consequences of systemic disorders (e.g. respiratory, metabolic, or renal disease) or local changes in perfusion (e.g. ischemia). Experimental or disease-related changes in the cellular acid extrusion machinery can also cause significant changes in pH_i even under normal extracellular acid–base conditions: the consequences of intracellular acid–base disturbances caused by altered expression of acid–base transporters have been studied most intensively based on vascular preparations from transgenic mice,^19,38 but there is also evidence that the pH_i regulatory function can vary in human VSMCs and ECs based on polymorphism in SLC4A7 coding for NBCn1⁸³ and in animal models of hypertension.^84–86

Intracellular acidification modifies artery tone via different pathways depending on the magnitude of the acidification and the rate of pH_i-change. Abrupt VSMC acidification of large magnitude (e.g. 0.5 units within tens of seconds) consistently causes vasoconstriction of resistance arteries independent of whether it is induced by hypercapnia or by addition or washout of acid–base pairs with differing membrane permeabilities (e.g. NH₄⁺/NH₃ or CH₃COOH/CH₃COO^–).^{36,43,87–89} The mechanism mediating the transient vasoconstriction caused by acute VSMC acidification is not yet completely clear. Most likely, contraction results from an increase in [Ca²⁺]_i elicited by competition between H⁺ and Ca²⁺ for intracellular buffer binding (Figure 2).^90,91 It is also possible that altered membrane excitability and transport of Ca²⁺ across cell or organelle membranes contribute to the vasocontractile response to acute VSMC acidification.^{17,43,92–96} Membrane depolarization during intracellular acidification may, for instance, be caused by inhibition of BK-channel activity (Figure 2).¹⁷ Under physiological and most pathophysiological conditions, acidification most realistically develops over a time course of minutes to hours, and these slower intracellular decreases of VSMC pH_i predominantly act by decreasing the Ca²⁺-sensitivity of the VSMC contractile machinery (Figure 2).^{19,24,35,38,44}

Inhibition of net acid extrusion via NBCn1 (Figures 1 and 2) causes sustained intracellular acidification of ECs and VSMCs.^19,35,44 In contrast, inhibition of NHE1 has sizable effects on steady-state pH_i only when arteries are investigated in the absence of CO₂/HCO₃^–.³⁸ When CO₂/HCO₃^– is omitted from the experimental bath solutions, NBCn1 is inactive due to lack of substrate and the otherwise dominant effect of Na⁺,HCO₃^–-cotransport for setting steady-state pH_i is eliminated.¹⁹ Studying tissue from NHE1 knockout mice both in the presence and absence of CO₂/HCO₃^– provides a valuable experimental tool for evaluating vasomotor effects of reversible intracellular acidification.³⁸ Acidification of ECs—by genetic disruption of NBCn1 in arteries investigated in the presence of CO₂/HCO₃^– or NHE1 in arteries investigated in the absence of CO₂/HCO₃^–—inhibits NO production (Figure 2).^19,38,44 In congruence, cell-free assays show that the activity of the endothelial NO-synthase is pH-dependent with optimum around 7.5 and substantial inhibition when pH decreases below the physiological range.²⁰ NBCn1 knockout mice are mildly hypertensive at rest and display reduced blood pressure increases in response to NO-synthase inhibition,¹⁹ which supports the conclusion that NO signaling is reduced in resistance arteries in vivo. Sustained acidification of VSMCs reduces the Ca²⁺-sensitivity of the contractile machinery in a rho-kinase-dependent manner;^19,38,44 and in accordance, the blood pressure of NBCn1 knockout mice is less sensitive to in vivo infusion of angiotensin II compared to corresponding wild type mice.¹⁹ Whereas the impact of NBCn1 in the vascular wall is well-established, more work is required to elucidate the role of NBCn1 in other blood pressure relevant organs such as the kidneys, nervous, and immune system.⁹⁷ In mouse middle cerebral arteries, knockout of NBCn1 decreases the NO-mediated inhibition and rho-kinase-mediated augmentation of myogenic tone development.⁴⁴ The attenuated vasomotor responses and reduced ability of cerebral arteries to respond to transmural pressure changes will likely lead to inappropriate fluctuations in cerebral perfusion and capillary pressure during variations in blood pressure. Lack of NBCn1 also inhibits the rhythmic, oscillatory contractile pattern, known as vasomotion, in middle cerebral arteries.⁴⁴ Although the physiological and/or pathophysiological significance of vasomotion is still unclear, reduced tissue oxygenation in individuals showing attenuated vasomotion has been proposed⁹⁸ and vasomotion may be impaired in Alzheimer’s disease.⁹⁹ Supporting the human cardiovascular relevance of Na⁺,HCO₃^–-cotransport and pH_i in the vascular wall, single nucleotide polymorphisms in SLC4A7 (rs13082711 and rs820430) are associated with human blood pressure variation,^100,101 increased NBCn1 expression,^83,102 and elevated Na⁺,HCO₃^–-cotransport activity and steady-state pH_i in VSMCs.⁸³

In addition to direct effects of extracellular H⁺ (see the section Extracellular H⁺ above), increasing evidence supports that extracellular acidification can relax arteries via secondary changes in pH_i (Figure 2). The decrease in VSMC Ca²⁺-sensitivity demonstrated during sustained intracellular acidification under standard conditions of pH_o 7.4^19,38,44 is also observed in mouse basilar arteries during extracellular acidification as evidenced by a greater reduction in artery tone than would be predicted based on the decrease in [Ca²⁺]_i alone.²⁴ Furthermore, complex effects of pH_i are reported for ryanodine receptor-mediated release of Ca²⁺ from intracellular stores:¹⁰³ in brain parenchymal arteries, extracellular acidosis—presumably via lowering of pH_i—was found to modulate sarcoplasmic reticulum Ca²⁺-release from a pattern dominated by Ca²⁺ waves at normal pH to mostly Ca²⁺ sparks at low pH. Hence, low pH was suggested to cause vasorelaxation by indirectly activating large-conductance Ca²⁺-activated K⁺-channels (BK_Ca-channels) via enhanced ryanodine-receptor-mediated Ca²⁺ release.⁷⁵ This effect is in contrast to the direct inhibitory effect of low pH_i on BK-channel activity observed in patch clamp experiments where [Ca²⁺]_i is kept constant.¹⁷ An additional proposed mechanism by which intracellular acidification—as primary disturbance or secondary to extracellular acidosis—can cause vasorelaxation is via activation of ATP-sensitive K⁺-channels (K_ATP channels)^76,77 that contain an intracellular activator site for H⁺ binding (Figure 2).¹⁰⁴

The contrasting vasomotor responses elicited by acute and sustained intracellular acidification are consistent with a major effect of H⁺ in the acute phase releasing Ca²⁺ as it shifts the protonation of intracellular buffers:^90,91 acute acidification has been found to cause a transient, membrane potential-independent increase in [Ca²⁺]_i that leads to contraction,⁹² but when the buffers have reached their new equilibrium, they provide a more or less normal buffering function as evidenced by unaffected Ca²⁺ responses during sustained acidification.^19,38,44 The more subtle effects of H⁺ on the Ca²⁺-sensitivity of the VSMC contractile machinery inhibit contractions during sustained acidification^19,38,44 but are most likely overwhelmed by the massive increase in intracellular [Ca²⁺] observed in the acute phase (Figure 2).

VSMC pH_i in basilar arteries is more sensitive to intracellular alkalinization than acidification, as pH_i changes are approximately 3-fold larger when the arteries are exposed to the same pH_o disturbance in the alkaline compared to the acidic direction.²⁴ Not much is known about the sensitivity of EC pH_i to changes in extracellular acid–base conditions. In ECs of mouse mesenteric arteries, intracellular alkalinization inhibits gap junctional communication between neighboring ECs and between ECs and VSMCs (Figure 2).⁵⁹ Because gap junctions in many vascular beds are important for conducted responses—typically, hyperpolarization traveling from capillaries or arterioles through cell-cell contacts to larger upstream feed arteries¹⁰⁵—and endothelium-dependent hyperpolarizations,^106–108 regulation of gap junctions by pH_i has potential implications for small artery function and local control of tissue perfusion. Indeed, alkalinization of ECs in mouse mesenteric arteries inhibits endothelium-dependent vasorelaxation by decreasing endothelium-dependent hyperpolarizations of VSMCs.⁵⁹ Inhibition of current transfer between ECs and VSMCs at elevated pH_i is confirmed by the finding that VSMC hyperpolarizations are absent, or very substantially reduced, despite normal EC hyperpolarizations.⁵⁹

Extracellular HCO₃^–

Sensing of acid–base parameters other than pH provides a mechanism for adjusting vascular resistance according to the cause of the acid–base disturbance. When [HCO₃^–] and/or pCO₂ are sensed in addition to pH, metabolic and respiratory disturbances give rise to separate downstream signaling events and differentiated vascular responses may be initiated, for instance, in response to fully or partially compensated systemic acid–base disturbances compared to local acid–base disturbances developed due to mismatch between local blood flow and metabolism.

Vasocontractile responses to decreases in [HCO₃^–]_o were recently demonstrated under out-of-equilibrium conditions, i.e. with pH_o maintained at 7.4 and CO₂ kept constant at 5%.²⁴ The regulation of vascular tone by extracellular HCO₃^– requires the single-pass transmembrane protein receptor protein tyrosine phosphatase (RPTP)γ, which is encoded by Ptprg and expressed in cerebral arteries.²⁴ Based on sequence similarity between the extracellular carbonic anhydrase-like domain of RPTPγ and the active site of the carbonic anhydrases, it is proposed that HCO₃^– binds to the extracellular aspect of RPTPγ and initiates cellular signaling responses via the intracellular phosphatase domain (Figure 2). RPTPγ is not expected to possess carbonic anhydrase activity as the carbonic anhydrase-like domain of RPTPγ lacks critical histidine residues required for catalytic activity.¹⁰⁹ Consistent with predominant Ptprg promoter activity in the vascular endothelium, the vasomotor effect of RPTPγ is endothelium-dependent.²⁴ The intra- and intercellular signaling pathways downstream of RPTPγ are still to be unraveled.

The vasocontractile response to decreases in [HCO₃^–]_o counteracts the predominant vasorelaxation caused by the reduction in pH_o during metabolic acidosis.²⁴ As discussed in more detail later (see the section Braking actions on vasorelaxation in response to extracellular acidosis), limiting vasorelaxation during acidosis could be important for tailoring the increase in capillary pressure, which if unopposed may lead to edema formation and capillary damage and thereby worsen the consequences of local inadequate perfusion.

Intracellular HCO₃^–

During acid–base disturbances, [HCO₃^–]_i changes as function of pH_i and pCO₂.²⁴ Although experimental verification is needed, it is possible that changes in [HCO₃^–]_i can modify vascular tone by altering the activity of the HCO₃^–-sensitive soluble adenylyl cyclase (sAC), which is expressed in vascular ECs (Figure 2).¹¹⁰ It is not yet clear that HCO₃^–-stimulated cAMP production has functional effects in the vascular wall but cAMP has been shown to modify intercellular coupling¹¹¹ and cause vasorelaxation at least partly through enhanced endothelial NO production.¹¹²

CO₂

The potential direct signaling role of molecular CO₂ for cerebrovascular relaxation during hypercapnic acidosis is still debated.⁴¹ Whereas experimental increases in pCO₂ under equilibrated conditions can be used to mimic respiratory acidosis, the net vasomotor response to hypercapnia is not evidence of a direct CO₂-induced effect: under standard experimental conditions, primary changes in pCO₂ inevitably lead to secondary changes in intra- and extracellular [H⁺] and/or [HCO₃^–]. Indeed, when pCO₂ is raised selectively under out-of-equilibrium conditions—i.e. without concomitant changes in pH_o or [HCO₃^–]_o—no net vasomotor effect of hyper- or hypocapnia is observed at steady-state.²⁴ Yet, abrupt simultaneous increases of pCO₂ and [HCO₃^–]_o—with pH_o maintained constant at 7.4—induce transient cerebrovascular contraction.^31,43 This acute CO₂/HCO₃^–-induced vasocontraction is attenuated by inhibition of intracellular carbonic anhydrases that—in the uninhibited state—increase the rate of CO₂ hydration and thereby accelerate and amplify the imposed pH_i decrease.³¹ These findings support that vasocontraction induced by acute hypercapnia most likely results from CO₂-induced intracellular acidification.

Taken together, the current evidence supports that the vasomotor effects of CO₂ act via decreases in pH_o and pH_i. The apparent absence of a direct CO₂-induced vasomotor effect is not contradictory to the well-established finding that respiratory acidosis causes vasorelaxation⁴¹ or that hyperventilation-induced respiratory alkalosis via cerebrovascular constriction can reduce capillary pressure and filtration to acutely alleviate increased intracranial pressure.¹¹³ Instead, changes in pH—perhaps with smaller contributions from concomitant changes in [HCO₃^–]—are the dominant signals leading to altered vascular tone during changes in pCO₂. Because intracellular and extracellular acidification can have opposing effects on VSMC contractions (see the sections Extracellular H⁺ and Intracellular H⁺), the net contractile response to primary changes in pCO₂ depends on the rate and magnitude of the secondary pH_i and pH_o fluctuations. Although CO₂ has no net vasomotor effect at steady-state—i.e. when the transient pH_i decrease has waned and the acid–base reactions have reached their new equilibria—we cannot fully exclude that CO₂ modifies several signaling pathways: CO₂ may for instance act both as a molecule per se and through pH_i and pH_o, and these individual effects could be opposing, resulting in no significant net effect.

Ion conductances sensitive to acid–base disturbances

A number of ion conductances are sensitive to local acid–base disturbances. As highlighted above (see the section Extracellular H⁺), pH-mediated inhibition of voltage-gated Ca²⁺-channels has been demonstrated in patch-clamp experiments and is considered a prominent underlying mechanism for vasorelaxation in response to extracellular acidosis.

K⁺-channels sensitive to pH (e.g. K_ATP-channels, BK_Ca-channels, and acid-sensing ion channels) have also been implicated in the local regulation of cerebrovascular tone.^75,114–116 In particular, K_ATP-channels are suggested to play major roles for metabolic regulation of blood flow: activation of K_ATP-channels in presence of a low [ATP]/[ADP] ratio and in response to hypercapnic acidosis supports that insufficient nutrient levels can influence the VSMC membrane potential (Figure 2).^117,118 The possibility that the VSMC membrane potential is affected by several acid–base parameters—e.g. extracellular and intracellular H⁺ as well as CO₂/HCO₃^– buffer components—is supported by the observation that hypercapnic acidosis hyperpolarizes, whereas normocapnic acidosis depolarizes rat cerebral arteries.⁴²

Even though patch clamp experiments have identified multiple pH_i-sensitive ion channels, our findings from isolated arteries support that sustained intracellular acid–base disturbances affect vascular tone mostly via changes in VSMC Ca²⁺-sensitivity independently of membrane excitability.^19,38,44

Braking actions on vasorelaxation in response to extracellular acidosis

The vasorelaxant response to extracellular acidification increases cerebral perfusion, for instance, in the ischemic penumbra and thus improves the immediate oxygen delivery. However, the drop in pre-capillary vascular resistance also tends to increase capillary pressures and filtration, which may have detrimental consequences by worsening the edema typical for ischemic tissue. Increasing the interstitial pressures within the non-distensible skull can also limit cerebral perfusion. Cerebrovascular tone should therefore be very accurately controlled during ischemia in order to optimize local perfusion without causing tissue injury due to elevated intracranial pressure.

As described in the sections Extracellular H⁺ and Intracellular H⁺, vasorelaxation in response to extracellular acidification depends on reductions in pH_o and sustained decreases in VSMC pH_i. More recently, it has been demonstrated that changes in local concentrations of acid–base buffers, principally [HCO₃^–]_o, modify the vasomotor response to pH disturbances. As discussed in the sections Extracellular HCO₃^– and CO₂, recent studies show that acute CO₂-dependent decreases in pH_i³¹ and reductions in [HCO₃^–]_o²⁴ elicit vasocontraction; and it is predicted that these contractions counteract the vasorelaxant response to decreases in pH_o during respiratory and metabolic acidosis, respectively. Effects of disturbed extracellular acid–base conditions on EC pH_i have not yet been settled. However, inhibition of NO synthesis by low EC pH_i^{19,20,38,44,119} represents a likely additional braking mechanism on vasorelaxation in response to extracellular acidosis.

The anti-relaxant influences of lowered [HCO₃^–]_o, reduced EC pH_i, and acutely decreased VSMC pH_i may seem counterintuitive at first because they oppose the predominant vasorelaxant response observed during extracellular acidification. Parallel activation of opposing signaling pathways, however, is in line with the observation that many vasocontractile agonists (e.g. endothelin-1 and insulin) activate both vasocontractile and vasorelaxant signaling, which can be unmasked if individual signaling pathways are inhibited.^120,121 Simultaneous activation of counteracting responses by the same agonist is typically explained by stimulation of multiple receptor subtypes and/or receptors in both ECs and VSMCs. Parallel activation of vasocontractile and vasorelaxant signaling pathways may prime the system to provide a more dynamic and accurate mode of vasomotor control than can be achieved with a simpler single-effector pathway.

Despite growing evidence that changes in pCO₂ and [HCO₃^–]_o limit the vasorelaxant response during acidosis either directly (e.g. HCO₃^– acting via RPTPγ)²⁴ or indirectly (e.g. CO₂ acting via pH_i),³¹ more experimental work is needed to clarify the physiological and pathophysiological implications. Particularly, the in vivo consequences of RPTPγ knockout for vascular responses and cerebral perfusion during systemic (i.e. metabolic or respiratory) and local (e.g. ischemia-associated) acid–base disturbances should be defined in order to verify the concept that simultaneous activation of multiple cellular signaling pathways by acid–base equivalents optimizes local perfusion while limiting the risk of cerebral edema.

Acid–base equivalents as second messengers in vasomotor control and structural adaptations

Because pH-changes modify the activity of functional proteins, including enzymes and ion channels important for cellular signaling events, H⁺ has been proposed as a second messenger: for instance, bradykinin causes sustained intracellular alkalinization of cultured ECs, and this increase in pH_i may serve as a persisting signal for activation of the intrinsically pH-sensitive endothelial NO-synthase when the transient intracellular Ca²⁺-response has waned.²⁰ Moreover, EC pH_i-changes in response to shear stress^122–124 may modify the activity of the endothelial NO-synthase and contribute to flow-mediated responses in artery tone. Rather than simply contributing to homeostasis, it is possible that local transport and sensing of acid–base equivalents can initiate dynamic tissue responses. Because the dynamic pH_i effects of agonists and shear-stress have primarily been suggested based on ECs in culture, additional work is required to determine if they exist in arteries and are of consequence for control of vascular tone development.

Considering the widespread effects of pH on multiple proteins and the possibility of generating pH_i and pH_o gradients within diffusion-restricted compartments, it is probable that H⁺ serves a second messenger role by spatially coordinating the activity of enzymes and other functional and structural proteins. This may be important, for instance, during cell migration where longitudinal pH gradients are observed along the axis of migration. NBCn1 is responsible for establishing pH_i gradients in migrating VSMCs and the migratory rate is substantially reduced when the pH_i gradients are experimentally diminished.⁵⁰ NHE1 does not generate similar spatial pH_i patterns under physiologically buffered conditions, but in the absence of CO₂/HCO₃^–, pH_i gradients re-appear in filopodia of VSMCs from NBCn1 knockout mice suggesting that NHE1 can generate spatial gradients for H⁺ when buffer capacity and buffer mobility are low.⁵⁰ NHE1 has also been suggested to facilitate cell migration and proliferation by serving as a scaffold for protein interactions and as an element in signaling cascades.⁵⁸ Consistent with a role for NHE1 in VSMC migration and arterial remodeling, mesenteric arteries from NHE1 knockout mice are thin-walled,³⁸ NHE1 knockout mice are protected against hypoxia-induced pulmonary hypertension and pulmonary artery remodeling,¹²⁵ and NHE1 knockdown has been found to inhibit proliferation and migration of isolated VSMCs.¹²⁶ So far, however, it remains unknown whether NBCn1 and/or NHE1 contribute to the plasticity of the cerebral vasculature, including generation of collateral blood vessels during hypoxia and in response to ischemic insults.

Other potential signals for metabolic blood flow regulation

In addition to changes in the concentrations of H⁺, CO₂, and HCO₃^–, other signals of insufficient local perfusion include decreases in pO₂ and increases in the concentrations of K⁺, lactate, and adenosine.¹⁶ [K⁺]_o has received particular interest because even moderate increases in the local concentration (e.g. to 10–15 mM, within the range observed in brain interstitial fluid during ischemia)¹²⁷ lead to vasorelaxation.¹²⁸ Confined increases in [K⁺]_o can hyperpolarize VSMCs locally¹²⁹ or act on capillary ECs that initiate retrograde conducted responses into the resistance arteries;¹³⁰ in both cases, inward-rectifier K⁺-channels are believed to act as the molecular sensors that are activated in response to the local rise in [K⁺]_o.

Lactate is generated in response to increased metabolism particularly under anaerobic conditions. The relevance of lactate as a signaling molecule in the vascular wall remains elusive but elevated concentrations of lactate have been found to reduce the responsiveness of VSMCs to vasoconstrictors.¹³¹ Adenosine is released from tissue during metabolic activity and can cause hyperpolarization and relaxation of VSMCs locally and signal to upstream feed arteries via conducted responses in the VSMC layer.^106,132,133 Thus, although vasomotor effects of lactate and adenosine need further investigation in the cerebrovascular wall, these markers of local increased, and possibly unmet, metabolic demand could contribute to metabolic regulation of cerebral blood flow.

As described above and illustrated in Figure 2, local signaling in the arterial wall involves a number of acid–base equivalents as well as other local waste products and signaling metabolites. The highlighted findings mostly relate to in vitro studies of artery function. Because the experimental conditions can be less precisely controlled under in vivo conditions, deciphering cellular signaling mechanisms in living animals is extremely challenging. It should be noted, however, that acid–base equivalents may also act on cells in the perivascular tissue and regulate vasomotor tone, for instance, via NO synthesized in perivascular nerves.¹³⁴ The relative contribution of the highlighted signals of insufficient local perfusion and other potential signaling molecules has not yet been established and more work—particularly integrated studies of cerebrovascular preparations from animals with targeted disruption of known and putative acid–base transporters and sensors (Figure 2)—is needed to clarify their physiological and pathophysiological importance.

Conclusions and perspectives

Responses to acid–base disturbances are complex with multiple pathways activated or inhibited by H⁺ and HCO₃^– acting inside or on the outside of VSMCs and ECs. The signaling pathways modulated by H⁺ and HCO₃^– act in parallel and have potential to fine-tune vascular tone and adapt blood flow in response to physiological and pathophysiological changes in the local metabolic demand. Recent evidence suggests that decreases in [HCO₃^–]_o and acute reductions in VSMC pH_i—possibly together with intracellular acidification of ECs—counteract the vasorelaxation induced by low pH_o. In this manner, sensing of the CO₂/HCO₃^– buffer composition can initiate downstream responses that protect against cerebral edema, which could otherwise be the consequence of unopposed vasodilation.

Understanding the mechanisms of acid–base-induced vasomotor control opens attractive prospects for new pharmacological approaches that can increase blood flow specifically in metabolically compromised tissue and reduce the consequences of ischemic cerebrovascular disease. Although suitable pharmacological tools against acid–base transporters and sensors are not yet available,^45,135,136 it is probable that spatial specificity to the ischemic region can be achieved by use of acid-activated compounds or by targeting cellular signaling pathways with increased activity under the disturbed acid–base conditions. Drugs that specifically dilate arteries supplying ischemic brain tissue and the surrounding penumbra will likely be much more effective than agents inducing generalized systemic vasodilation: universal vasodilation can decrease the cerebral perfusion pressure and lead to vascular intracerebral steal phenomena¹³⁷ where blood is re-routed from ischemic tissue and brain regions with borderline perfusion to heathy parts of the circulation with larger blood flow reserve. Pharmacological treatment modalities that improve blood flow particularly in the ischemic penumbra may minimize the infarct size and buy the clinician enough time to implement relevant revascularization procedures.

Footnotes

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Related work in the author’s laboratory was supported financially by the Danish Council for Independent Research (grants no. 10-094816 and 4183-00258B), the Lundbeck Foundation (grant no. R93-2011-8859), the Danish Heart Foundation (grants no. 08-10-R68-A2179-B719-22494 and 14-R97-A5321-22809), and the Novo Nordisk Foundation (grants no. 2131 and 7393).

Declaration of conflicting interests

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Ebbe Boedtkjer is inventor on a patent application describing tools for manipulating acid–base transport.

References

Aalbaek

Bonde

Kim

et al.

Perivascular tissue inhibits rho-kinase-dependent smooth muscle Ca²⁺ sensitivity and endothelium-dependent H₂S signalling in rat coronary arteries. J Physiol 2015; 593: 4747–4764.

Bonde

Shokouh

Jeppesen

et al.

Crosstalk between cardiomyocyte-rich perivascular tissue and coronary arteries is reduced in the Zucker Diabetic Fatty rat model of type 2 diabetes mellitus. Acta Physiol 2017; 219: 227–238.

Zavaritskaya

Zhuravleva

Schleifenbaum

et al.

Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction. Hypertension 2013; 61: 151–159.

Greenstein

Khavandi

Withers

et al.

Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119: 1661–1670.

Verlohren

Dubrovska

Tsang

et al.

Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44: 271–276.

Lynch

Withers

Yao

et al.

Perivascular adipose tissue-derived adiponectin activates BK_Ca channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 2013; 304: H786–H795.

Lohn

Dubrovska

Lauterbach

et al.

Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16: 1057–1063.

Talman

Nitschke Dragon

. Neuronal nitric oxide mediates cerebral vasodilatation during acute hypertension. Brain Res 2007; 1139: 126–132.

Attwell

Buchan

Charpak

et al.

Glial and neuronal control of brain blood flow. Nature 2010; 468: 232–243.

10.

Sarelius

Pohl

. Control of muscle blood flow during exercise: local factors and integrative mechanisms. Acta Physiol 2010; 199: 349–365.

11.

Bell

Yellon

. Conditioning the whole heart – not just the cardiomyocyte. J Mol Cell Cardiol 2012; 53: 24–32.

12.

Kovács

Heinemann

Steinhäuser

. Mechanisms underlying blood–brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia. Epilepsia 2012; 53: 53–59.

13.

Nicolakakis

Hamel

. Neurovascular function in Alzheimer’s disease patients and experimental models. J Cereb Blood Flow Metab 2011; 31: 1354–1370.

14.

Aghamohammadzadeh

Greenstein

Yadav

et al.

Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. J Am Coll Cardiol 2013; 62: 128–135.

15.

Simonsen

Boedtkjer

. New roles of factors from perivascular tissue in regulation of vascular tone. Acta Physiol 2016; 216: 159–162.

16.

Girouard

Iadecola

. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006; 100: 328–335.

17.

Schubert

Krien

Gagov

. Protons inhibit the BK_Ca channel of rat small artery smooth muscle cells. J Vasc Res 2001; 38: 30–38.

18.

Klockner

Isenberg

. Calcium channel current of vascular smooth muscle cells: extracellular protons modulate gating and single channel conductance. J Gen Physiol 1994; 103: 665–678.

19.

Boedtkjer

Praetorius

Matchkov

et al.

Disruption of Na⁺,HCO₃^– cotransporter NBCn1 (slc4a7) inhibits NO-mediated vasorelaxation, smooth muscle Ca²⁺-sensitivity and hypertension development in mice. Circulation 2011; 124: 1819–1829.

20.

Fleming

Hecker

Busse

. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res 1994; 74: 1220–1226.

21.

Ahn

Beningo

Olds

et al.

The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1992; 89: 8606–8610.

22.

Trivedi

Danforth

. Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem 1966; 241: 4110–4112.

23.

Seuwen

Ludwig

Wolf

. Receptors for protons or lipid messengers or both? J Recept Signal Transduct Res 2006; 26: 599–610.

24.

Boedtkjer

Hansen

Boedtkjer

et al.

Extracellular HCO₃⁻ is sensed by mouse cerebral arteries: regulation of tone by receptor protein tyrosine phosphatase γ. J Cereb Blood Flow Metab 2016; 36: 965–980.

25.

Zhou

Skelton

et al.

Role of receptor protein tyrosine phosphatase γ in sensing extracellular CO₂ and HCO₃^-. J Am Soc Nephrol 2016; 27: 2616–2621.

26.

Chen

Cann

Litvin

et al.

Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 2000; 289: 625–628.

27.

Radu

Nijagal

McLaughlin

et al.

Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci U S A 2005; 102: 1632–1637.

28.

Ludwig

Vanek

Guerini

et al.

Proton-sensing G-protein-coupled receptors. Nature 2003; 425: 93–98.

29.

Corredor

Trakhtenberg

Pita-Thomas

et al.

Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth. J Neurosci 2012; 32: 7734–7744.

30.

Zhao

Hogan

Bevensee

et al.

Out-of-equilibrium CO₂/HCO₃^- solutions and their use in characterizing a new K/HCO₃ cotransporter. Nature 1995; 374: 636–639.

31.

Rasmussen

Boedtkjer

. Carbonic anhydrase inhibitors modify intracellular pH transients and contractions of rat middle cerebral arteries during CO₂/HCO₃⁻ fluctuations. J Cereb Blood Flow Metab. Epub ahead of print 20 March 2017. DOI: 10.1177/0271678X17699224.

32.

Nyvad

Mazur

Postnov

et al.

Intravital investigation of rat mesenteric small artery tone and blood flow. J Physiol 2017; 595: 5037–5053.

33.

Boedtkjer

Aalkjaer

. Insulin inhibits Na⁺/H⁺ exchange in vascular smooth muscle and endothelial cells in situ: involvement of H₂O₂ and tyrosine phosphatase SHP-2. Am J Physiol Heart Circ Physiol 2009; 296: H247–H255.

34.

Lin

Schnitzer

. Genetically encoded indicators of neuronal activity. Nat Neurosci 2016; 19: 1142–1153.

35.

Boedtkjer

Praetorius

Aalkjaer

. NBCn1 (slc4a7) mediates the Na⁺-dependent bicarbonate transport important for regulation of intracellular pH in mouse vascular smooth muscle cells. Circ Res 2006; 98: 515–523.

36.

Aalkjaer

Cragoe

Jr . Intracellular pH regulation in resting and contracting segments of rat mesenteric resistance vessels. J Physiol 1988; 402: 391–410.

37.

Aickin

. Regulation of intracellular pH in smooth muscle cells of the guinea-pig femoral artery. J Physiol 1994; 479: 331–340.

38.

Boedtkjer

Damkier

Aalkjaer

. NHE1 knockout reduces blood pressure and arterial media/lumen ratio with no effect on resting pH_i in the vascular wall. J Physiol 2012; 590: 1895–1906.

39.

Tian

Vogel

Lassen

et al.

Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries. Circ Res 1995; 76: 269–275.

40.

Bonde

Boedtkjer

. Extracellular acidosis and very low [Na⁺] inhibit NBCn1- and NHE1-mediated net acid extrusion from mouse vascular smooth muscle cells. Acta Physiol 2017; 221: 129–141.

41.

Yoon

Zuccarello

Rapoport

. pCO₂ and pH regulation of cerebral blood flow. Front Physiol 2012; 3: 365.

42.

Peng

Jensen

Nilsson

et al.

Effect of acidosis on tension and [Ca²⁺]_i in rat cerebral arteries: is there a role for membrane potential?

Am J Physiol 1998; 274: H655–H662.

43.

Nielsen

Aalkjaer

Mulvany

. Differential contractile effects of changes in carbon dioxide tension on rat mesenteric resistance arteries precontracted with noradrenaline. Pflugers Arch 1991; 419: 51–56.

44.

Thomsen

ABK

Kim

Aalbaek

et al.

Intracellular acidification alters myogenic responsiveness and vasomotion of mouse middle cerebral arteries. J Cereb Blood Flow Metab 2014; 34: 161–168.

45.

Boedtkjer

Bunch

Pedersen

. Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences and implications for cancer therapy. Curr Pharm Des 2012; 18: 1345–1371.

46.

Boedtkjer

Aalkjaer

. Intracelullar pH in the resistance vasculature: regulation and functional implications. J Vasc Res 2012; 49: 479–496.

47.

Boedtkjer

Matchkov

Boedtkjer

DMB

et al.

Negative news: Cl^- and HCO₃^- in the vascular wall. Physiology 2016; 31: 370–383.

48.

Aronson

Nee

Suhm

. Modifier role of internal H⁺ in activating the Na⁺-H⁺ exchanger in renal microvillus membrane vesicles. Nature 1982; 299: 161–163.

49.

Wakabayashi

Fafournoux

Sardet

et al.

The Na⁺/H⁺ antiporter cytoplasmic domain mediates growth factor signals and controls “H⁺-sensing”. Proc Natl Acad Sci U S A 1992; 89: 2424–2428.

50.

Boedtkjer

Bentzon

Dam

et al.

Na⁺,HCO₃^–-cotransporter NBCn1 increases pH_i gradients, filopodia and migration of smooth muscle cells and promotes arterial remodeling. Cardiovasc Res 2016; 111: 227–239.

51.

Daugirdas

Arrieta

et al.

Intracellular acidification associated with changes in free cytosolic calcium. Evidence for Ca²⁺/H⁺ exchange via a plasma membrane Ca²⁺-ATPase in vascular smooth muscle cells. J Clin Invest 1995; 95: 1480–1489.

52.

Aalkjaer

Mulvany

. Steady-state effects of arginine vasopressin on force and pH_i of isolated mesenteric resistance arteries from rats. Am J Physiol 1991; 261: C1010–C1017.

53.

Naderali

Buttell

Taggart

et al.

The role of the sarcolemmal Ca²⁺-ATPase in the pH transients associated with contraction in rat smooth muscle. J Physiol 1997; 505: 329–336.

54.

Danielsen

Parker

Lee

et al.

Splice cassette II of NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions. J Biol Chem 2013; 288: 8146–8155.

55.

Gill

Roush

Dutcher

et al.

Direct evidence for calcineurin binding to the exon-7 loop of the sodium-bicarbonate cotransporter NBCn1. Int J Biol Sci 2014; 10: 771–776.

56.

Besse

Tanguy

Boucher

et al.

Protection of endothelial-derived vasorelaxation with cariporide, a sodium-proton exchanger inhibitor, after prolonged hypoxia and hypoxia-reoxygenation: effect of age. Eur J Pharmacol 2006; 531: 187–193.

57.

Symons

Schaefer

. Na⁺/H⁺ exchange subtype 1 inhibition reduces endothelial dysfunction in vessels from stunned myocardium. Am J Physiol Heart Circ Physiol 2001; 281: H1575–H1582.

58.

Boedtkjer

Aalkjaer

. Acid-base transporters modulate cell migration, growth and proliferation: implications for structure development and remodelling of resistance arteries? Trends Cardiovasc Med 2013; 23: 59–65.

59.

Boedtkjer

Kim

Aalkjaer

. Endothelial alkalinisation inhibits gap junction communication and endothelium-derived hyperpolarisations in mouse mesenteric arteries. J Physiol 2013; 591: 1447–1461.

60.

Aalkjaer

Hughes

. Chloride and bicarbonate transport in rat resistance arteries. J Physiol 1991; 436: 57–73.

61.

Brosius

III Pisoni

Cao

et al.

AE anion exchanger mRNA and protein expression in vascular smooth muscle cells, aorta, and renal microvessels. Am J Physiol 1997; 273: F1039–F1047.

62.

Davis

Chien

Chipperfield

et al.

The three mechanisms of intracellular chloride accumulation in vascular smooth muscle of human umbilical and placental arteries. Pflugers Arch 2000; 441: 150–154.

63.

Spitzer

Skolnick

Peercy

et al.

Facilitation of intracellular H⁺ ion mobility by CO₂/HCO₃^- in rabbit ventricular myocytes is regulated by carbonic anhydrase. J Physiol 2002; 541: 159–167.

64.

Hartmann

Perley

Barnett

. A study of some of the physiological effects of sulfanilamide. I. Changes in the acid base balance. J Clin Invest 1938; 17: 465–472.

65.

Leaf

Goldfarb

. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 2007; 102: 1313–1322.

66.

Démolis

Florence

Thomas

et al.

Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study. Stroke 2000; 31: 508–515.

67.

Pickkers

Hughes

Russel

et al.

In vivo evidence for K_Ca channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol 2001; 132: 443–450.

68.

Domoki

Zimmermann

Toth-Szuki

et al.

Acetazolamide induces indomethacin and ischaemia-sensitive pial arteriolar vasodilation in the piglet. Acta Paediatr 2008; 97: 280–284.

69.

Kringelholt

Simonsen

Bek

. Dorzolamide-induced relaxation of intraocular porcine ciliary arteries in vitro depends on nitric oxide and the vascular endothelium. Curr Eye Res 2012; 37: 1107–1113.

70.

Shimoda

Luke

Sylvester

et al.

Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1002–L1012.

71.

Torring

Holmgaard

Hessellund

et al.

The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition. Invest Ophthalmol Vis Sci 2009; 50: 345–351.

72.

El-Galaly

Aalkjaer

Kringelholt

et al.

Dorzolamide-induced relaxation of porcine retinal arterioles in vitro depends on nitric oxide but not on acidosis in vascular smooth muscle cells. Exp Eye Res 2014; 128: 67–72.

73.

Pickkers

Garcha

Schachter

et al.

Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension 1999; 33: 1043–1048.

74.

Peng

Ivarsen

Nilsson

et al.

On the cellular mechanism for the effect of acidosis on vascular tone. Acta Physiol Scand 1998; 164: 517–525.

75.

Dabertrand

Nelson

Brayden

. Acidosis dilates brain parenchymal arterioles by conversion of calcium waves to sparks to activate BK channels. Circ Res 2012; 110: 285–294.

76.

Rosenblum

Wei

Kontos

. Vasodilation of brain surface arterioles by blockade of Na–H⁺ antiport and its inhibition by inhibitors of K_ATP channel openers. Brain Res 2004; 1005: 77–83.

77.

Horiuchi

Dietrich

Hongo

et al.

Role of endothelial nitric oxide and smooth muscle potassium channels in cerebral arteriolar dilation in response to acidosis. Stroke 2002; 33: 844–849.

78.

West

Leppla

Simard

. Effects of external pH on ionic currents in smooth muscle cells from the basilar artery of the guinea pig. Circ Res 1992; 71: 201–209.

79.

Wendling

Harakal

. Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin. Stroke 1987; 18: 591–598.

80.

Potocnik

Murphy

Kotecha

et al.

Effects of mibefradil and nifedipine on arteriolar myogenic responsiveness and intracellular Ca²⁺. Br J Pharmacol 2000; 131: 1065–1072.

81.

Chen

Bezprozvanny

Tsien

. Molecular basis of proton block of L-type Ca²⁺ channels. J Gen Physiol 1996; 108: 363–374.

82.

Kawasaki

Eguchi

Miyashita

et al.

Proton acts as a neurotransmitter for nicotine-induced adrenergic and calcitonin gene-related peptide-containing nerve-mediated vasodilation in the rat mesenteric artery. J Pharmacol Exp Ther 2009; 330: 745–755.

83.

Boedtkjer

Witkowska

et al.

Increased NBCn1 expression, Na⁺/HCO₃^- co-transport and intracellular pH in human vascular smooth muscle cells with a risk allele for hypertension. Hum Mol Genet 2017; 26: 989–1002.

84.

Izzard

Heagerty

. The measurement of internal pH in resistance arterioles: evidence that intracellular pH is more alkaline in SHR than WKY animals. J Hypertens 1989; 7: 173–180.

85.

Scuteri

Jensen

Aalkjaer

. The regulation of pH in resistance arteries from spontaneously hypertensive and Wistar-Kyoto rats: the effect of bicarbonate. J Hypertens 1995; 13: 523–528.

86.

Orlov

Adarichev

Devlin

et al.

Increased Na⁺/H⁺ exchanger isoform 1 activity in spontaneously hypertensive rats: lack of mutations within the coding region of NHE1. Biochim Biophys Acta 2000; 1500: 169–180.

87.

Apkon

Boron

. Extracellular and intracellular alkalinization and the constriction of rat cerebral arterioles. J Physiol 1995; 484: 743–753.

88.

Aalkjaer

Mulvany

. Effect of changes in intracellular pH on the contractility of rat resistance vessels. Prog Biochem Pharmacol 1988; 23: 150–158.

89.

Matthews

Graves

Poston

. Relationships between pH_i and tension in isolated rat mesenteric resistance arteries. J Vasc Res 1992; 29: 330–340.

90.

Batlle

Peces

LaPointe

et al.

Cytosolic free calcium regulation in response to acute changes in intracellular pH in vascular smooth muscle. Am J Physiol 1993; 264: C932–C943.

91.

Abercrombie

Hart

. Calcium and proton buffering and diffusion in isolated cytoplasm from Myxicola axons. Am J Physiol 1986; 250: C391–C405.

92.

Jensen

Hughes

Boonen

et al.

Force, membrane potential, and [Ca²⁺]_i during activation of rat mesenteric small arteries with norepinephrine, potassium, aluminum fluoride, and phorbol ester. Effects of changes in pH_i. Circ Res 1993; 73: 314–324.

93.

Raingo

Rebolledo

Grassi de Gende

et al.

pH effects on high conductance Ca²⁺-activated K⁺ channels (BK_Ca) in human internal mammary artery smooth muscle cells. Life Sci 2005; 77: 1993–2003.

94.

Restini

Bendhack

. Involvement of non-selective Ca²⁺ channels in the contraction induced by alkalinization of rat anococcygeus muscle cells. Eur J Pharmacol 2006; 553: 288–296.

95.

Kozak

Matsushita

Nairn

et al.

Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J Gen Physiol 2005; 126: 499–514.

96.

Park

Kim

Sim

et al.

Regulation of membrane excitability by intracellular pH (pH_i) changers through Ca²⁺-activated K⁺ current (BK channel) in single smooth muscle cells from rabbit basilar artery. Pflugers Arch 2007; 454: 307–319.

97.

Boedtkjer

Aalkjaer

. Disturbed acid-base transport: an emerging cause of hypertension. Front Physiol 2013; 4: 388.

98.

Aalkjaer

Boedtkjer

Matchkov

. Vasomotion - what is currently thought? Acta Physiol 2011; 202: 253–269.

99.

Di Marco

Farkas

Martin

et al.

Is vasomotion in cerebral arteries impaired in Alzheimer’s disease?

J Alzheimers Dis 2015; 46: 35–53.

100.

Ehret

Munroe

Rice

et al.

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478: 103–109.

101.

Wang

Lin

et al.

Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum Mol Genet 2014; 24: 865–874.

102.

Wang

Yang

et al.

The hypertension risk variant rs820430 functions as an enhancer of SLC4A7. Am J Hypertens 2016; 30: 202–208.

103.

Wray

Burdyga

. Sarcoplasmic reticulum function in smooth muscle. Physiol Rev 2010; 90: 113–178.

104.

Cui

Yang

et al.

Direct activation of cloned K_ATP channels by intracellular acidosis. J Biol Chem 2001; 276: 12898–12902.

105.

Jensen

Holstein-Rathlou

N-H

. The vascular conducted response in cerebral blood flow regulation. J Cereb Blood Flow Metab 2013; 33: 649–656.

106.

de Wit

. Different pathways with distinct properties conduct dilations in the microcirculation in vivo. Cardiovasc Res 2010; 85: 604–613.

107.

Looft-Wilson

Payne

Segal

. Connexin expression and conducted vasodilation along arteriolar endothelium in mouse skeletal muscle. J Appl Physiol 2004; 97: 1152–1158.

108.

Garland

Dora

. EDH: endothelium-dependent hyperpolarization and microvascular signalling. Acta Physiol 2017; 219: 152–161.

109.

Barnea

Silvennoinen

Shaanan

et al.

Identification of a carbonic anhydrase-like domain in the extracellular region of RPTPγ defines a new subfamily of receptor tyrosine phosphatases. Mol Cell Biol 1993; 13: 1497–1506.

110.

Obiako

Calchary

et al.

Bicarbonate disruption of the pulmonary endothelial barrier via activation of endogenous soluble adenylyl cyclase, isoform 10. Am J Physiol Lung Cell Mol Physiol 2013; 305: L185–L192.

111.

Griffith

Chaytor

Taylor

et al.

cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions. Proc Natl Acad Sci U S A 2002; 99: 6392–6397.

112.

García-Morales

Cuíñas

Elíes

et al.

PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production. Vascul Pharmacol 2014; 60: 95–101.

113.

Freeman

. Management of intracranial pressure. Continuum 2015; 21: 1299–1323.

114.

Drummond

Jernigan

Grifoni

. Sensing tension: epithelial sodium channel/acid-sensing ion channel proteins in cardiovascular homeostasis. Hypertension 2008; 51: 1265–1271.

115.

Kinoshita

Katusic

. Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke 1997; 28: 433–438.

116.

Wei

Kontos

. Blockade of ATP-sensitive potassium channels in cerebral arterioles inhibits vasoconstriction from hypocapnic alkalosis in cats. Stroke 1999; 30: 851–854.

117.

Taggart

Wray

. Hypoxia and smooth muscle function: key regulatory events during metabolic stress. J Physiol 1998; 509: 315–325.

118.

Rosenblum

Kontos

Wei

. Evidence for a K_ATP ion channel link in the inhibition of hypercapnic dilation of pial arterioles by 7-nitroindazole and tetrodotoxin. Eur J Pharmacol 2001; 417: 203–215.

119.

Aalkjaer

Boedtkjer

Choi

et al.

Cation-coupled bicarbonate transporters. Compr Physiol 2014; 4: 1605–1637.

120.

Eringa

Stehouwer

CDA

Merlijn

et al.

Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc Res 2002; 56: 464–471.

121.

Schneider

Boesen

Pollock

. Contrasting actions of endothelin ET_A and ET_B receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 2007; 47: 731–759.

122.

Ziegelstein

Blank

Cheng

et al.

Cytosolic alkalinization of vascular endothelial cells produced by an abrupt reduction in fluid shear stress. Circ Res 1998; 82: 803–809.

123.

Ziegelstein

Cheng

Capogrossi

. Flow-dependent cytosolic acidification of vascular endothelial cells. Science 1992; 258: 656–659.

124.

Wittstein

Qiu

Ziegelstein

et al.

Opposite effects of pressurized steady versus pulsatile perfusion on vascular endothelial cell cytosolic pH: role of tyrosine kinase and mitogen-activated protein kinase signaling. Circ Res 2000; 86: 1230–1236.

125.

Quinn

Garg

et al.

Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 2008; 177: 1276–1284.

126.

Hales

. Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1. Am J Respir Cell Mol Biol 2011; 45: 923–930.

127.

Schielke

Moises

Betz

. Blood to brain sodium transport and interstitial fluid potassium concentration during early focal ischemia in the rat. J Cereb Blood Flow Metab 1991; 11: 466–471.

128.

Kuschinsky

Wahl

Bosse

et al.

Perivascular potassium and pH as determinants of local pial arterial diameter in cats. Circ Res 1972; 31: 240–247.

129.

McNeish

Dora

Garland

. Possible role for K⁺ in endothelium-derived hyperpolarizing factor–linked dilatation in rat middle cerebral artery. Stroke 2005; 36: 1526–1532.

130.

Longden

Dabertrand

Koide

et al.

Capillary K⁺-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow. Nat Neurosci 2017; 20: 717–726.

131.

Barron

Nair

. Lactate depresses sarcolemmal permeability of Ca²⁺ in intact arterial smooth muscle. Life Sci 2003; 74: 651–662.

132.

Soricelli

Postiglione

Cuocolo

et al.

Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. Stroke 1995; 26: 1572–1576.

133.

Winn

Morii

Berne

. The role of adenosine in autoregulation of cerebral blood flow. Ann Biomed Eng 1985; 13: 321–328.

134.

Lindauer

Kunz

Schuh-Hofer

et al.

Nitric oxide from perivascular nerves modulates cerebral arterial pH reactivity. Am J Physiol Heart Circ Physiol 2001; 281: H1353–H1363.

135.

Larsen

Krogsgaard-Larsen

Lauritzen

et al.

Gram-scale solution-phase synthesis of selective sodium bicarbonate co-transport inhibitor S0859: in vitro efficacy studies in breast cancer cells. Chem Med Chem 2012; 7: 1808–1814.

136.

Steinkamp

A-D

Seling

Lee

et al.

Synthesis of N-cyano-substituted sulfilimine and sulfoximine derivatives of S0859 and their biological evaluation as sodium bicarbonate co-transport inhibitors. Med Chem Comm 2015; 6: 2163–2169.

137.

Arteaga

Strother

Faraco

et al.

The vascular steal phenomenon is an incomplete contributor to negative cerebrovascular reactivity in patients with symptomatic intracranial stenosis. J Cereb Blood Flow Metab 2014; 34: 1453–1462.

138.

Swietach

Youm

J-B

Saegusa

et al.

Coupled Ca²⁺/H⁺ transport by cytoplasmic buffers regulates local Ca²⁺ and H⁺ ion signaling. Proc Natl Acad Sci U S A 2013; 110: E2064–E2073.

139.

Gonzalez-Nieto

Gomez-Hernandez

Larrosa

et al.

Regulation of neuronal connexin-36 channels by pH. Proc Natl Acad Sci U S A 2008; 105: 17169–17174.

140.

Swietach

Rossini

Spitzer

et al.

H⁺ ion activation and inactivation of the ventricular gap junction: a basis for spatial regulation of intracellular pH. Circ Res 2007; 100: 1045–1054.

141.

Turin

Warner

. Carbon dioxide reversibly abolishes ionic communication between cells of early amphibian embryo. Nature 1977; 270: 56–57.

142.

Spray

Harris

Bennett

. Gap junctional conductance is a simple and sensitive function of intracellular pH. Science 1981; 211: 712–715.

Acid–base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone

Abstract

Keywords

Acid–base regulation in the vascular wall

Net acid extrusion

Net base extrusion

Carbonic anhydrases

Sensing of acid–base disturbances

Extracellular H+

Intracellular H+

Extracellular HCO3–

Intracellular HCO3–

CO2

Ion conductances sensitive to acid–base disturbances

Braking actions on vasorelaxation in response to extracellular acidosis

Acid–base equivalents as second messengers in vasomotor control and structural adaptations

Other potential signals for metabolic blood flow regulation

Conclusions and perspectives

Footnotes

Funding

Declaration of conflicting interests

References

Extracellular H⁺

Intracellular H⁺

Extracellular HCO₃^–

Intracellular HCO₃^–

CO₂